APO Research
Talk to an analyst

APO RESEARCH · REPORT

Risperidone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Risperidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchRisperidone Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Risperidone Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Risperidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Risperidone Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Risperidone Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Risperidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Risperidone include Ajanta Pharma, Amneal Pharmaceuticals, Apotex, Aurobindo Pharma, Celltrion, Dr. Reddy's Laboratories, Hikma, Lannett and Luye Pharma Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Risperidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Risperidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Risperidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Risperidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Risperidone Segment by Company

Ajanta Pharma

Amneal Pharmaceuticals

Apotex

Aurobindo Pharma

Celltrion

Dr. Reddy's Laboratories

Hikma

Lannett

Luye Pharma Group

Torrent Pharmaceuticals

Tris Pharma

Janssen (Johnson & Johnson)

Sandoz

Risperidone Segment by Type

Tablet

Oral Solution

Risperidone Segment by Application

Schizophrenia

Bipolar Disorder

Risperidone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Risperidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Risperidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Risperidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Risperidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Risperidone Industry Trends Table 2. Risperidone Industry Drivers Table 3. Risperidone Industry Opportunities and Challenges Table 4. Risperidone Industry Restraints Table 5. Global Risperidone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Risperidone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Risperidone Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Risperidone Sales Market Share by Manufacturers Table 9. Global Risperidone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Risperidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Risperidone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Risperidone Manufacturers, Product Type & Application Table 13. Global Risperidone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Risperidone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Oral Solution Table 18. Global Risperidone Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Risperidone Sales by Type (2021-2026) & (W Units) Table 20. Global Risperidone Sales by Type (2027-2032) & (W Units) Table 21. Global Risperidone Sales Market Share by Type (2021-2026) Table 22. Global Risperidone Sales Market Share by Type (2027-2032) Table 23. Global Risperidone Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Risperidone Revenue by Type (2021-2026) & (W Units) Table 25. Global Risperidone Revenue by Type (2027-2032) & (W Units) Table 26. Global Risperidone Revenue Market Share by Type (2021-2026) Table 27. Global Risperidone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Schizophrenia Table 29. Major Manufacturers of Bipolar Disorder Table 30. Global Risperidone Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 31. Global Risperidone Sales by Application (2021-2026) & (W Units) Table 32. Global Risperidone Sales by Application (2027-2032) & (W Units) Table 33. Global Risperidone Sales Market Share by Application (2021-2026) Table 34. Global Risperidone Sales Market Share by Application (2027-2032) Table 35. Global Risperidone Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Risperidone Revenue by Application (2021-2026) & (W Units) Table 37. Global Risperidone Revenue by Application (2027-2032) & (W Units) Table 38. Global Risperidone Revenue Market Share by Application (2021-2026) Table 39. Global Risperidone Revenue Market Share by Application (2027-2032) Table 40. Global Risperidone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 41. Global Risperidone Sales by Region (2021-2026) & (W Units) Table 42. Global Risperidone Sales Market Share by Region (2021-2026) Table 43. Global Risperidone Sales Forecasted by Region (2027-2032) & (W Units) Table 44. Global Risperidone Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 46. North America Risperidone Sales by Country (2021-2026) & (W Units) Table 47. North America Risperidone Sales by Country (2027-2032) & (W Units) Table 48. Europe Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. Europe Risperidone Sales by Country (2021-2026) & (W Units) Table 50. Europe Risperidone Sales by Country (2027-2032) & (W Units) Table 51. Asia Pacific Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Asia Pacific Risperidone Sales by Country (2021-2026) & (W Units) Table 53. Asia Pacific Risperidone Sales by Country (2027-2032) & (W Units) Table 54. South America, Middle East and Africa Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. South America, Middle East and Africa Risperidone Sales by Country (2021-2026) & (W Units) Table 56. South America, Middle East and Africa Risperidone Sales by Country (2027-2032) & (W Units) Table 57. Global Risperidone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Risperidone Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Risperidone Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Risperidone Revenue Market Share by Region (2021-2026) Table 61. Global Risperidone Revenue Market Share by Region (2027-2032) Table 62. Ajanta Pharma Company Information Table 63. Ajanta Pharma Business Overview Table 64. Ajanta Pharma Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Ajanta Pharma Risperidone Product Portfolio Table 66. Ajanta Pharma Recent Development Table 67. Amneal Pharmaceuticals Company Information Table 68. Amneal Pharmaceuticals Business Overview Table 69. Amneal Pharmaceuticals Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Amneal Pharmaceuticals Risperidone Product Portfolio Table 71. Amneal Pharmaceuticals Recent Development Table 72. Apotex Company Information Table 73. Apotex Business Overview Table 74. Apotex Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Apotex Risperidone Product Portfolio Table 76. Apotex Recent Development Table 77. Aurobindo Pharma Company Information Table 78. Aurobindo Pharma Business Overview Table 79. Aurobindo Pharma Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Aurobindo Pharma Risperidone Product Portfolio Table 81. Aurobindo Pharma Recent Development Table 82. Celltrion Company Information Table 83. Celltrion Business Overview Table 84. Celltrion Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Celltrion Risperidone Product Portfolio Table 86. Celltrion Recent Development Table 87. Dr. Reddy's Laboratories Company Information Table 88. Dr. Reddy's Laboratories Business Overview Table 89. Dr. Reddy's Laboratories Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Dr. Reddy's Laboratories Risperidone Product Portfolio Table 91. Dr. Reddy's Laboratories Recent Development Table 92. Hikma Company Information Table 93. Hikma Business Overview Table 94. Hikma Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Hikma Risperidone Product Portfolio Table 96. Hikma Recent Development Table 97. Lannett Company Information Table 98. Lannett Business Overview Table 99. Lannett Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Lannett Risperidone Product Portfolio Table 101. Lannett Recent Development Table 102. Luye Pharma Group Company Information Table 103. Luye Pharma Group Business Overview Table 104. Luye Pharma Group Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Luye Pharma Group Risperidone Product Portfolio Table 106. Luye Pharma Group Recent Development Table 107. Torrent Pharmaceuticals Company Information Table 108. Torrent Pharmaceuticals Business Overview Table 109. Torrent Pharmaceuticals Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Torrent Pharmaceuticals Risperidone Product Portfolio Table 111. Torrent Pharmaceuticals Recent Development Table 112. Tris Pharma Company Information Table 113. Tris Pharma Business Overview Table 114. Tris Pharma Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Tris Pharma Risperidone Product Portfolio Table 116. Tris Pharma Recent Development Table 117. Janssen (Johnson & Johnson) Company Information Table 118. Janssen (Johnson & Johnson) Business Overview Table 119. Janssen (Johnson & Johnson) Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Janssen (Johnson & Johnson) Risperidone Product Portfolio Table 121. Janssen (Johnson & Johnson) Recent Development Table 122. Sandoz Company Information Table 123. Sandoz Business Overview Table 124. Sandoz Risperidone Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Sandoz Risperidone Product Portfolio Table 126. Sandoz Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Risperidone Distributors List Table 130. Risperidone Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Risperidone Product Image Figure 2. Global Risperidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Risperidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Risperidone Sales (2021-2032) & (W Units) Figure 5. Global Risperidone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Risperidone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Oral Solution Image Figure 10. Global Risperidone Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Risperidone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Risperidone Sales Market Share by Type (2021-2032) Figure 13. Global Risperidone Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Risperidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Risperidone Revenue Market Share by Type (2021-2032) Figure 16. Schizophrenia Image Figure 17. Bipolar Disorder Image Figure 18. Global Risperidone Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Risperidone Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Risperidone Sales Market Share by Application (2021-2032) Figure 21. Global Risperidone Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Risperidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Risperidone Revenue Market Share by Application (2021-2032) Figure 24. North America Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 25. North America Risperidone Sales Market Share by Country (2021-2032) Figure 26. U.S. Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 27. Canada Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Mexico Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Europe Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Risperidone Sales Market Share by Country (2021-2032) Figure 31. Germany Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 32. France Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 33. U.K. Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Italy Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Netherlands Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Asia Pacific Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Risperidone Sales Market Share by Country (2021-2032) Figure 38. China Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Japan Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 40. South Korea Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Southeast Asia Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 42. India Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Australia Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South America, Middle East and Africa Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Risperidone Sales Market Share by Country (2021-2032) Figure 46. Brazil Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Africa Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Saudi Arabia Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Turkey Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Argentina Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 51. UAE Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Egypt Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Chile Risperidone Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Global Risperidone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Risperidone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Risperidone Revenue (2021-2032) & (US$ Million) Figure 57. North America Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Risperidone Revenue (2021-2032) & (US$ Million) Figure 59. Europe Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Risperidone Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Risperidone Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Risperidone Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Risperidone Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Schizophrenia
  • Bipolar Disorder
Companies covered
  • Ajanta Pharma
  • Amneal Pharmaceuticals
  • Apotex
  • Aurobindo Pharma
  • Celltrion
  • Dr. Reddy's Laboratories
  • Hikma
  • Lannett
  • Luye Pharma Group
  • Torrent Pharmaceuticals
  • Tris Pharma
  • Janssen (Johnson & Johnson)
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Risperidone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Risperidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Risperidone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Risperidone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Risperidone Market Dynamics
  1. 2.1 Risperidone Industry Trends
  2. 2.2 Risperidone Industry Drivers
  3. 2.3 Risperidone Industry Opportunities and Challenges
  4. 2.4 Risperidone Industry Restraints
3 Risperidone Market by Manufacturers
  1. 3.1 Global Risperidone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Risperidone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Risperidone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Risperidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Risperidone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Risperidone Manufacturers, Product Type & Application
  7. 3.7 Global Risperidone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Risperidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Risperidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Risperidone Tier 1, Tier 2, and Tier 3
4 Risperidone Market by Type
  1. 4.1 Risperidone Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Solution
  4. 4.2 Global Risperidone Sales by Type
  5. 4.2.1 Global Risperidone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Risperidone Sales by Type (2021-2032)
  7. 4.2.3 Global Risperidone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Risperidone Revenue by Type
  9. 4.3.1 Global Risperidone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Risperidone Revenue by Type (2021-2032)
  11. 4.3.3 Global Risperidone Revenue Market Share by Type (2021-2032)
5 Risperidone Market by Application
  1. 5.1 Risperidone Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Bipolar Disorder
  4. 5.2 Global Risperidone Sales by Application
  5. 5.2.1 Global Risperidone Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Risperidone Sales by Application (2021-2032)
  7. 5.2.3 Global Risperidone Sales Market Share by Application (2021-2032)
  8. 5.3 Global Risperidone Revenue by Application
  9. 5.3.1 Global Risperidone Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Risperidone Revenue by Application (2021-2032)
  11. 5.3.3 Global Risperidone Revenue Market Share by Application (2021-2032)
6 Global Risperidone Sales by Region
  1. 6.1 Global Risperidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Risperidone Sales by Region (2021-2032)
  3. 6.2.1 Global Risperidone Sales by Region (2021-2026)
  4. 6.2.2 Global Risperidone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Risperidone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Risperidone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Risperidone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Risperidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Risperidone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Risperidone Revenue by Region
  1. 7.1 Global Risperidone Revenue by Region
  2. 7.1.1 Global Risperidone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Risperidone Revenue by Region (2021-2026)
  4. 7.1.3 Global Risperidone Revenue by Region (2027-2032)
  5. 7.1.4 Global Risperidone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Risperidone Revenue (2021-2032)
  8. 7.2.2 North America Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Risperidone Revenue (2021-2032)
  11. 7.3.2 Europe Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Risperidone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Risperidone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Risperidone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajanta Pharma
  2. 8.1.1 Ajanta Pharma Company Information
  3. 8.1.2 Ajanta Pharma Business Overview
  4. 8.1.3 Ajanta Pharma Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ajanta Pharma Risperidone Product Portfolio
  6. 8.1.5 Ajanta Pharma Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Risperidone Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Apotex
  14. 8.3.1 Apotex Company Information
  15. 8.3.2 Apotex Business Overview
  16. 8.3.3 Apotex Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Apotex Risperidone Product Portfolio
  18. 8.3.5 Apotex Recent Developments
  19. 8.4 Aurobindo Pharma
  20. 8.4.1 Aurobindo Pharma Company Information
  21. 8.4.2 Aurobindo Pharma Business Overview
  22. 8.4.3 Aurobindo Pharma Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aurobindo Pharma Risperidone Product Portfolio
  24. 8.4.5 Aurobindo Pharma Recent Developments
  25. 8.5 Celltrion
  26. 8.5.1 Celltrion Company Information
  27. 8.5.2 Celltrion Business Overview
  28. 8.5.3 Celltrion Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Celltrion Risperidone Product Portfolio
  30. 8.5.5 Celltrion Recent Developments
  31. 8.6 Dr. Reddy's Laboratories
  32. 8.6.1 Dr. Reddy's Laboratories Company Information
  33. 8.6.2 Dr. Reddy's Laboratories Business Overview
  34. 8.6.3 Dr. Reddy's Laboratories Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dr. Reddy's Laboratories Risperidone Product Portfolio
  36. 8.6.5 Dr. Reddy's Laboratories Recent Developments
  37. 8.7 Hikma
  38. 8.7.1 Hikma Company Information
  39. 8.7.2 Hikma Business Overview
  40. 8.7.3 Hikma Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Risperidone Product Portfolio
  42. 8.7.5 Hikma Recent Developments
  43. 8.8 Lannett
  44. 8.8.1 Lannett Company Information
  45. 8.8.2 Lannett Business Overview
  46. 8.8.3 Lannett Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lannett Risperidone Product Portfolio
  48. 8.8.5 Lannett Recent Developments
  49. 8.9 Luye Pharma Group
  50. 8.9.1 Luye Pharma Group Company Information
  51. 8.9.2 Luye Pharma Group Business Overview
  52. 8.9.3 Luye Pharma Group Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Luye Pharma Group Risperidone Product Portfolio
  54. 8.9.5 Luye Pharma Group Recent Developments
  55. 8.10 Torrent Pharmaceuticals
  56. 8.10.1 Torrent Pharmaceuticals Company Information
  57. 8.10.2 Torrent Pharmaceuticals Business Overview
  58. 8.10.3 Torrent Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Torrent Pharmaceuticals Risperidone Product Portfolio
  60. 8.10.5 Torrent Pharmaceuticals Recent Developments
  61. 8.11 Tris Pharma
  62. 8.11.1 Tris Pharma Company Information
  63. 8.11.2 Tris Pharma Business Overview
  64. 8.11.3 Tris Pharma Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tris Pharma Risperidone Product Portfolio
  66. 8.11.5 Tris Pharma Recent Developments
  67. 8.12 Janssen (Johnson & Johnson)
  68. 8.12.1 Janssen (Johnson & Johnson) Company Information
  69. 8.12.2 Janssen (Johnson & Johnson) Business Overview
  70. 8.12.3 Janssen (Johnson & Johnson) Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Janssen (Johnson & Johnson) Risperidone Product Portfolio
  72. 8.12.5 Janssen (Johnson & Johnson) Recent Developments
  73. 8.13 Sandoz
  74. 8.13.1 Sandoz Company Information
  75. 8.13.2 Sandoz Business Overview
  76. 8.13.3 Sandoz Risperidone Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sandoz Risperidone Product Portfolio
  78. 8.13.5 Sandoz Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Risperidone Value Chain Analysis
  2. 9.1.1 Risperidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Risperidone Production Mode & Process
  6. 9.2 Risperidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Risperidone Distributors
  9. 9.2.3 Risperidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst